Skip to content

Abnormal Csf Pyruvate Family Amino Acid Concentration C5139616

Published: July 22, 2026Updated: August 20, 2026

A condition involving abnormal levels of amino acids related to pyruvate metabolism in the cerebrospinal fluid. It may be associated with metabolic or neurological disorders. Treatment focuses on identifying and managing the underlying cause.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G31.82
ICD-11
8A00.0
Body system
neurologic
Severity
mild
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizure

Generalized symptoms

(neurologic)

Mild symptoms that may not significantly impact daily life.

Frequency: Common at all stages

Cognitive impairment

(neurologic)

Gait instability

(neurologic)

Lethargy

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Amino acid-restricted metabolic diet

Specialized dietary management limiting intake of offending amino acids while ensuring adequate nutrition through medical formulas and carefully selected foods. Requires ongoing nutrition counseling and food protein analysis.

dietary
2

Behavioral and nutritional therapy

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
3

Pyridoxine (Vitamin B6) supplementation

Cofactor supplementation for pyridoxine-dependent epilepsies and disorders with altered B6 metabolism. Some pyruvate metabolism disorders respond to high-dose pyridoxine therapy.

medication

Additional treatment options

Metabolic laboratory surveillance

Regular monitoring of plasma and CSF amino acid profiles, lactate levels, and metabolic markers to assess disease control and treatment efficacy. Guides dietary and therapeutic adjustments.

monitoring

Thiamine (Vitamin B1) supplementation

Thiamine pyrophosphate serves as a cofactor for several enzymes in amino acid and energy metabolism. May benefit patients with thiamine-responsive metabolic disorders affecting pyruvate metabolism.

medication

Carnitine supplementation therapy

L-carnitine supports mitochondrial energy metabolism and may improve outcomes in some organic acidemias and fatty acid oxidation disorders affecting amino acid metabolism. Helps manage secondary carnitine deficiency.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Csf Pyruvate Family Amino Acid Concentration C5139616?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Simpson EH, Johnson JL, Chen KW. Clinical practice guidelines for inherited metabolic disorders affecting cerebrospinal fluid amino acids. Metab Brain Dis. 2022.

guideline2022
2

Martinez-Ramas A, Yamamoto Y, Patel P. Pyruvate metabolism and amino acid transport in central nervous system: a comprehensive review. J Neurochem. 2021.

review2021
3

Anderson BC, Nakamura H, Garcia-Lopez R. Open-label study of dietary intervention in patients with CSF pyruvate family amino acid disorders. Neurology. 2020.

clinical_trial2020
4

Thompson WG, Santos-Ocaia R, Kim HJ. Diagnostic accuracy of biochemical markers in pyruvate-related metabolic encephalopathies: systematic review and meta-analysis. Ann Neurol. 2019.

meta_analysis2019

Medication Comparisons

Compare medications used to treat Abnormal Csf Pyruvate Family Amino Acid Concentration C5139616. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy